Skip NavigationSkip to Content

Humanized monoclonal antibody against the chemokine CXCL-8 (IL-8) effectively prevents acute lung injury

  1. Author:
    Bao, Z. Y.
    Ye, Q. W.
    Gong, W. H.
    Xiang, Y.
    Wan, H. Y.
  2. Author Address

    [Wan, HuanYing] Shanghai Jiao Tong Univ, Dept Pulm Med, Ruijin Hosp, Sch Med, Shanghai 200025, Peoples R China. [Ye, QingWei] Yes Biotech Labs Ltd, Mississauga, ON L5S1V6, Canada. [Gong, WangHua] SAIC Frederick, Basic Res Program, Frederick, MD USA.;Wan, HY, Shanghai Jiao Tong Univ, Dept Pulm Med, Ruijin Hosp, Sch Med, Shanghai 200025, Peoples R China.;huan_yin2000@yahoo.com
    1. Year: 2010
    2. Date: Feb
  1. Journal: International Immunopharmacology
    1. 10
    2. 2
    3. Pages: 259-263
  2. Type of Article: Article
  3. ISSN: 1567-5769
  1. Abstract:

    As one of the most important endogenous chemotactic factors for neutrophils, the chemokine CXCL8 (IL-8) is involved in the pathogenesis of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS), characterized by massive neutrophil infiltration in the lung. Since neutralization of CXCL8 with polyclonal antibody has been shown to reduce the severity of ALI/ARDS in animal models, we explored the potential of humanized anti-CXCL8 antibody as a preventive or therapeutic agent for ALI. We used a 'two-hit' protocol to induce ALI in rabbits that showed extensive edema in the alveolar lumina, marked infiltration of neutrophils in the lung tissue, fibrin deposition in alveolar space, and destruction of pulmonary architecture, culminating in severe hypoxemia. Concomitant challenge with endotoxin after priming with oleic acid (OA) induced a marked elevation of CXCL8 level in bronchoalveolar lavage fluid. Treatment of the rabbits with a humanized anti-CXCL8 antibody prevented neutrophil infiltration in the lung in association with alleviated ALI syndrome. Our results indicate a promising future for utilization of humanized anti-CXCL8 antibody in the prevention and treatment of ALI and ARDS in human. (C) 2009 Published by Elsevier B.V.

    See More

External Sources

  1. DOI: 10.1016/j.intimp.2009.11.005
  2. WOS: 000275381400017

Library Notes

  1. Fiscal Year: FY2009-2010
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel